CStone Pharmaceuticals (HK:2616) has released an update. CStone Pharmaceuticals has announced that its partner Jiangsu Hengrui Pharmaceuticals Co., Ltd. has begun a Phase III clinical trial for an anti-CTLA-4-based combination
CStone Pharmaceuticals (HK:2616) has released an update. CStone Pharmaceuticals has announced that its partner Jiangsu Hengrui Pharmaceuticals Co., Ltd. has begun a Phase III clinical trial for an anti-CTLA-4-based combination
New Universe Environmental Group Limited (HK:0436) has released an update. New Universe Environmental Group Limited has announced its Board of Directors, effective from 1 October 2024, including Executive Directors led
Sands China (HK:1928) has released an update. Sands China Ltd. has announced a change in its registered office and principal share registrar and transfer office in the Cayman Islands, effective
Shunten International (Holdings) Ltd. (HK:0932) has released an update. Shunten International (Holdings) Ltd. has announced that Mr. Liu Ying Shun has stepped down as an independent non-executive Director and chair
Great Wall Motor Co (HK:2333) has released an update. Great Wall Motor Company Limited has announced that they will not be issuing an interim dividend for the first half of